Embecta (Nasdaq:EMBC) announced that it appointed Nimish Muzumdar as its new SVP and president, North America. Muzumdar holds responsibility for leading the company’s U.S. and Canada commercial teams, executing the region’s long-term growth strategy. He reports to Chair, President and CEO, Dev Kurdikar, and serves on the Embecta operating team. His appointment went into effect […]
Personnel
Tandem Diabetes Care terminates chief commercial officer
Tandem Diabetes Care (Nasdaq:TNDM) recently said in an SEC filing that it terminated the employment of chief commercial officer Mark Novara. The SEC Form 8-K, filed on May 15, says that the company notified Novara, an EVP in addition to serving as CCO, on May 11 that his employment was being terminated without cause. The […]
CGM maker Sava names new chief commercial officer
Sava Technologies today announced the appointment of John Bernard as its new chief commercial officer (CCO). London-based Sava, which develops a minimally invasive molecular sensing platform for continuous glucose monitoring (CGM), says the appointment marks a “decisive step” in its transition from clinical and technical progress to commercial execution. The company designed its multi-molecule biosensor […]
Kevin Sayer returns from leave of absence to chair Dexcom board
Dexcom (Nasdaq:DXCM) announced today in an SEC filing that former CEO Kevin Sayer has returned from his leave of absence. Sayer notified the San Diego-based continuous glucose monitor (CGM) maker of his plan to return on Feb. 27, 2026. His return went into effect today, March 2, 2026, according to the filing. Upon his return, […]
Narcan nasal spray maker Emergent BioSolutions has a new CEO
Emergent BioSolutions (NSYE:EBS) announced today that it appointed Joseph C. Papa as its new president and CEO. Papa’s appointment to the corner office of the Gaithersburg, Maryland-based company went into effect today. He succeeds Haywood Miller, who stepped down from his role as interim CEO today as well. Emergent BioSolutions is known for its Narcan […]
Insulet has new directors as former CEO is set to retire from board
Insulet (Nasdaq:PODD) announced today that it named a duo of new board directors with high-profile figures set to retire. Acton, Massachusetts-based Insulet appointed Flavia Pease and Timothy Stonesifer to its board. Former CEO Shacey Petrovic, along with Corinne Nevinny, intend to retire from the board in May. Petrovic spent more than seven years as CEO […]
Implantable CGM maker Glucotrack names new VP of marketing
Glucotrack (Nasdaq:GCTK) announced that it appointed Drinda Benjamin as its new vice president of marketing. Rutherford, New Jersey-based Glucotrack develops an implantable continuous glucose monitor (CGM). It designed its CGM for patients with type 1 and type 2 insulin-dependent diabetes. A recent feasibility study demonstrated reliable glucose measurements for two years post-implant for the device. […]
Dexcom appoints a new board director
Dexcom (Nasdaq:DXCM) announced today that it appointed Rimma Driscoll to its board of directors. The San Diego-based continuous glucose monitor (CGM) maker made Driscoll’s appointment effective on Aug. 24. She currently serves as EVP and head of global strategy, commercial and business development and global biodevices for Zoetis. At Zoetis, a leading animal health company […]
Cell Pouch System developer Sernova announces CEO transition
Sernova announced today that, as part of a planned leadership succession process, Dr. Philip Toleikis will transition out of the CEO role. Toleikis spent 13 years leading the Cell Pouch System developer as president and CEO. He remains an executive at the company as the planned transition moves him to chief technology officer (CTO). Additionally, […]
Insulet CEO Jim Hollingshead talks leadership in a time of change
Insulet (Nasdaq:PODD) CEO Jim Hollingshead says his current field in some ways marks his third different career path. He began as an academic, then went into consulting. The former ResMed executive took over in the corner office at Insulet following CEO Shacey Petrovic’s departure for personal reasons earlier this year. He’s served on Insulet’s board since […]
